Welcome to the OMA Blog
The Obesity Medicine Association Blog is the leading industry hub for obesity medicine. Find the latest research, expert insights, and practical tips to tackle the multifaceted disease of obesity. Hear from OMA Outreach Committee members, OMA Board members, and more to gain a deeper understanding of the complex factors influencing obesity and explore innovative approaches to prevention, treatment, and long-term management. Join a community of healthcare professionals, researchers, and individuals passionate about combating obesity.
View by Category
Pediatric Research Update: Integrating Advocacy with Patient-Centered Care: How a Shared Decision-Making and Team-Based Approach can Improve Perioperative Period GLP-1RA Treatment Integrity
This article reviews new perioperative guidance on GLP-1RA therapy, emphasizing a team-based approach to reduce surgical risks while supporting continuity of treatment for adolescents with obesity.
OMA Applauds Plan to Cover Obesity Medications Under Medicare and Medicaid
The Trump Administration has announced a proposed plan for a five-year pilot program that will allow patients with Medicare or Medicaid access to anti-obesity medications.
Neuromusculoskeletal Health in Pediatric Obesity: Incorporating Evidence into Clinical Examination
This article highlights how obesity in childhood can impair strength, balance, gait, and joint health, emphasizing the importance of routine neuromusculoskeletal screening to support early intervention and improve physical function.
Top Weight Loss Medications
Discover the most effective weight loss medications approved by the FDA. Comprehensive guide on safety, dosage, and efficacy for 2025.
It’s Time to Change the Way We Treat Obesity and Provide Access to Care
We need an operation warp speed for obesity medicine. Healthcare systems , insurers, and employers are still falling short on our mission of radically changing what obesity looks like in the U.S. and providing access to the full suite of effective obesity treatment interventions including medications that are proven to help patients manage their condition.
GLP-1 Access, Safety, and the Road Ahead: What Advocates Need to Know
At Lilly, we know healthcare providers are looking to us to deliver real medicine—medicine that has been rigorously trialed and tested and that has been manufactured in accordance with the highest standards for safety and quality.
Early Reinitiation of Obesity Pharmacotherapy Post Laparoscopic Sleeve Gastrectomy in Youth: A Retrospective Cohort Study
This retrospective study found that in adolescents who had bariatric surgery, standard post-operative care plus early reinitiation of anti-obesity medication (AOM) led to greater weight loss and better eating behaviors than standard post-operative care alone.
Cardiovascular Benefits of Treating Obesity: Practical Approaches for Physicians
Although cardiovascular disease remains a significant concern, many of its risk factors can be managed, and in some cases, even reversed. One of the most effective ways to support heart health is through weight loss.
2025 American Medical Association (AMA) Annual Meeting Delegate Report
The AMA held its Annual Meeting in Chicago from June 6–11, 2025. I was honored to continue in this role and was joined by our alternate delegate, Dr. Jennifer Paisley. I’d like to share several highlights from this year’s meeting.